SIGN UP
LOG IN
L
LYEL
Lyell Immunopharma, Inc.
0.45
-0.02-3.60%After Hours: 0.4500 -0.00 -0.04%19:22 04/25 EDT
OPEN/PREV CLOSE0.4590/0.4670
TODAY RANGE0.4217-0.4780
VOL612.64K
MARKET CAP132.96M
52 WEEK RANGE0.3931-2.875
AVG VOL (3M)989.92K
% TURNOVER0.21%
TURNOVER--
P/E (TTM)-0.3432
% RANGE12.06%
EPS(TTM)-1.3117
P/E(FORWARD)-0.6253
P/B0.3468
BVPS1.298
DIVIDEND--
P/S2,251.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP102.46M
SHARES OUTSTANDING295.34M
NEXT EARNINGS05/06-05/20
FREE FLOAT227.59M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·04/16 11:38
Lyell Immunopharma Price Target Maintained With a $1.00/Share by HC Wainwright & Co.
Seeking Alpha·04/15 15:02
Lyell Immunopharma gets FDA RMAT status for lymphoma treatment
TipRanks·04/15 13:05
Lyell Immunopharma announces FDA granted RMAT designation to LYL314
TipRanks·04/03 02:04
Director’s Bold Move: Major Stock Purchase in Lyell Immunopharma!
TipRanks·04/01 21:29
Lyell Immunopharma’s LyFE Center Begins IMPT-314 Production
Reuters·04/01 21:02
LYELL IMMUNOPHARMA INC: REITERATES ITS FINANCIAL GUIDANCE
TipRanks·03/28 13:36
Bank of America Securities Keeps Their Sell Rating on Lyell Immunopharma (LYEL)
NASDAQ·03/26 18:10
Wednesday 3/26 Insider Buying Report: LYEL, LSAK
TipRanks·03/21 16:00
Biotech Alert: Searches spiking for these stocks today
Simply Wall St·03/20 10:02
Chief Financial Officer of Lyell Immunopharma Charles Newton Buys 989% More Shares
Benzinga·03/19 17:06
12 Health Care Stocks Moving In Wednesday's Intraday Session
Dow Jones·03/13 10:49
Lyell Immunopharma Price Target Maintained With a $1.00/Share by HC Wainwright & Co.
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.